These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27013967)

  • 21. Neuroinflammation and white matter pathology in schizophrenia: systematic review.
    Najjar S; Pearlman DM
    Schizophr Res; 2015 Jan; 161(1):102-12. PubMed ID: 24948485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural brain changes in schizophrenia at different stages of the illness: A selective review of longitudinal magnetic resonance imaging studies.
    Dietsche B; Kircher T; Falkenberg I
    Aust N Z J Psychiatry; 2017 May; 51(5):500-508. PubMed ID: 28415873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia.
    Milleit B; Smesny S; Rothermundt M; Preul C; Schroeter ML; von Eiff C; Ponath G; Milleit C; Sauer H; Gaser C
    Front Cell Neurosci; 2016; 10():33. PubMed ID: 27013967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Voxel-based morphometric analysis of gray matter in first episode schizophrenia.
    Kubicki M; Shenton ME; Salisbury DF; Hirayasu Y; Kasai K; Kikinis R; Jolesz FA; McCarley RW
    Neuroimage; 2002 Dec; 17(4):1711-9. PubMed ID: 12498745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White matter abnormalities in subjects at ultra high-risk for schizophrenia and first-episode schizophrenic patients.
    Witthaus H; Brüne M; Kaufmann C; Bohner G; Ozgürdal S; Gudlowski Y; Heinz A; Klingebiel R; Juckel G
    Schizophr Res; 2008 Jul; 102(1-3):141-9. PubMed ID: 18515047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study.
    Whitford TJ; Grieve SM; Farrow TF; Gomes L; Brennan J; Harris AW; Gordon E; Williams LM
    Am J Psychiatry; 2007 Jul; 164(7):1082-9. PubMed ID: 17606660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study.
    Steiner J; Bernstein HG; Bielau H; Farkas N; Winter J; Dobrowolny H; Brisch R; Gos T; Mawrin C; Myint AM; Bogerts B
    J Psychiatr Res; 2008 Aug; 42(10):868-76. PubMed ID: 18001771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. White matter alterations in first episode treatment-naïve patients with deficit schizophrenia: a combined VBM and DTI study.
    Lei W; Li N; Deng W; Li M; Huang C; Ma X; Wang Q; Guo W; Li Y; Jiang L; Zhou Y; Hu X; McAlonan GM; Li T
    Sci Rep; 2015 Aug; 5():12994. PubMed ID: 26257373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of Gray Matter Abnormalities in Schizophrenia Based on an International Mega-analysis.
    Gupta CN; Calhoun VD; Rachakonda S; Chen J; Patel V; Liu J; Segall J; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar J; Fisher SE; Fernandez G; van Erp TG; Potkin S; Ford J; Mathalon D; McEwen S; Lee HJ; Mueller BA; Greve DN; Andreassen O; Agartz I; Gollub RL; Sponheim SR; Ehrlich S; Wang L; Pearlson G; Glahn DC; Sprooten E; Mayer AR; Stephen J; Jung RE; Canive J; Bustillo J; Turner JA
    Schizophr Bull; 2015 Sep; 41(5):1133-42. PubMed ID: 25548384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review and meta-analysis of circulating S100B blood levels in schizophrenia.
    Aleksovska K; Leoncini E; Bonassi S; Cesario A; Boccia S; Frustaci A
    PLoS One; 2014; 9(9):e106342. PubMed ID: 25202915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder.
    Hercher C; Chopra V; Beasley CL
    J Psychiatry Neurosci; 2014 Nov; 39(6):376-85. PubMed ID: 24936776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum S100B represents a new biomarker for mood disorders.
    Schroeter ML; Sacher J; Steiner J; Schoenknecht P; Mueller K
    Curr Drug Targets; 2013 Oct; 14(11):1237-48. PubMed ID: 23701298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. White matter alterations in early stages of schizophrenia: a systematic review of diffusion tensor imaging studies.
    Samartzis L; Dima D; Fusar-Poli P; Kyriakopoulos M
    J Neuroimaging; 2014; 24(2):101-10. PubMed ID: 23317110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - a combined serum, gene expression and MRI study.
    Streitbürger DP; Arelin K; Kratzsch J; Thiery J; Steiner J; Villringer A; Mueller K; Schroeter ML
    PLoS One; 2012; 7(8):e43284. PubMed ID: 22916238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia.
    Katsel P; Byne W; Roussos P; Tan W; Siever L; Haroutunian V
    Neuropsychopharmacology; 2011 May; 36(6):1171-7. PubMed ID: 21270770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipocytes as an Important Source of Serum S100B and Possible Roles of This Protein in Adipose Tissue.
    Gonçalves CA; Leite MC; Guerra MC
    Cardiovasc Psychiatry Neurol; 2010; 2010():790431. PubMed ID: 20672003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phospholipase A2 activity is associated with structural brain changes in schizophrenia.
    Smesny S; Milleit B; Nenadic I; Preul C; Kinder D; Lasch J; Willhardt I; Sauer H; Gaser C
    Neuroimage; 2010 Oct; 52(4):1314-27. PubMed ID: 20478385
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.